Stroke Conference News Today

Primary effectiveness endpoint results show high revascularization rates of 93.9% mTICI 2b/3

This exploratory analysis of the SELECT2 trial assesses the relationship between imaging estimates of irreversibly injured brain (core) and at-risk regions (mis

Medtronic (NYSE: MDT) today announced new cost-effectiveness data from a study looking at its Reveal Linq insertable cardiac monitor (ICM).

Administering gingko biloba extract shortly after a stroke may help with cognitive recovery, according to a new study.

Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field MR brain imaging to aid physicians in the diagnosis of acute ischemic stroke ...

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company ad...

Researchers say Black women under the age of 35 who have high blood pressure have triple the risk of having a stroke

Irvine, Calif., Jan. 30, 2024 — Bernadette Boden-Albala, M.P.H., Dr.P.H., director of the University of California, Irvine Program in Public Health and foundi

DiaMedica Presents the Protocol and Rationale for ReMEDy2, a Pivotal Trial in Patients Suffering Acute Ischemic Stroke Ineligible for tPA and/or Mechanical Thrombectomy ...

The TENSION trial, which was stopped early for efficacy, selected patients using widely available non-contrast CT or CT angiography and should lead to more patients being considered for treatment.